GlassScriptPhysician profile
Charles C Alston
NPI 1922070382
$1,308.85
in general payments reported to CMS, 2019-2025
13 companies · $60.13 in 2025
The $60.13 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.10 · 2020: $109 · 2021: $288 · 2022: $417 · 2023: $324 · 2024: $43.85 · 2025: $60.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $447.47 | 2020-2025 | Acessa Provu System, Coolseal Generator, Myosure Tissue Removal Device |
| Abbvie INC. | $273.26 | 2019-2022 | |
| Myriad Women'S Health, INC. | $171.19 | 2023 | Myrisk |
| Agile Therapeutics, INC. | $90.70 | 2021-2023 | Twirla |
| Myovant Sciences INC. | $90.61 | 2021-2022 | |
| Organon LLC | $54.14 | 2021-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $37.44 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $31.32 | 2023 | Myfembree |
| Astellas Pharma US INC | $27.70 | 2025 | Veozah |
| Pacira Pharmaceuticals Incorporated | $26.59 | 2024 | Exparel |
| Janssen Pharmaceuticals, INC | $23.08 | 2021 | |
| Avion Pharmaceuticals | $23.06 | 2022 | |
| Dysis Medical, INC. | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Alston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.